The U.S. Food and Drug Administration (FDA) has granted Breakthrough Designation for ResistancePlus® GC - expediting the path towards clearance. This is the first commercially available molecular test that can...
PlexPCR® RespiVirus received clearance from the Australian Therapeutic Goods Administration (TGA), bringing much needed workflow advantages in time for the busy 2019 flu season. The test utilises market-leading multiplex technology...
Dr. Klausner, a clinical professor at UCLA, shares the details of his work with genotypic testing for ciprofloxacin susceptibility in Neisseria gonorrhoeae. The study found that routine gyrA genotyping can be...
SpeeDx announced further series A funding received by new investor partners, Northpond Ventures, LP – a U.S.-based, formative stage venture capital fund with a strong science and technology driven portfolio....
SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® tests for use on the GeneXpert System. The first test in Cepheid’s FleXible Cartridge programme, planned for...
ResistancePlus® MG will be the first test available through Cepheid's FleXible cartridge program. This partnership will increase access for clinicians and support Resistance Guided Therapy in the management of Mycoplasma...
SpeeDx have successfully started their U.S. journey by joining the Texas Health CoLab in Austin Texas. Chosen for its synergy in supporting progressive and innovative health solutions, the technology hub...
New distribution partners, Al Zahrawi Medical Supplies LLC, will distribute SpeeDx ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman, Bahrain, and Qatar. “Al Zahrawi Medical are the leading medical and...
ResistancePlus® GC received clearance from the Australian Therapeutic Goods Administration (TGA) today. Launched in December with CE-IVD mark for sale in Europe, Australian laboratories can now access this world-first diagnostic...
SpeeDx announced submission of the PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA), with anticipated clearance in time for the Australian 2019 flu season. The test utilises market-leading PlexPCR®...